Patient Advisory Board Booklet

The Patient Advisory Board (PAB) is responsible for identifying and making suggestions regarding patients concerns and expectations on the remit of EURO-NMD.
The PAB will establish their own rules of procedures and Terms of Reference.
Find out about the PAB in the latest version of their booklet (July 2019)
Patient Advisory Board - Booklet
2019 Version of PAB booklet

The Patient Advisory Board (PAB) comprises of the European Patient Advocacy Group (ePAG) which is made up of 7 patient organisations elected through a process put in place by EURORDIS for patient organisations in general, as well as invited umbrella patient organisations which will encourage and empower patients to participate in our activities, strategy development and research.

The network is fully committed to delivering a patient-centric approach ensuring patients are represented at every stage of developement. Patients will also be empowered though formal roles in the project via the Patient Advisory Board and representation on the other key boards and specialist groups. This will ensure the high level involvement of patients in the decision making, as experts in their diseases, which will manifest through contribution to early project work on guidelines, outcome measures and advances in diagnostics, which are important to rare disease patients.

Chair of Patient Advisory Board
François Lamy
AFM Téléthon
France

Members of Patient Advisory Board - ePAG
Dimitrios Athanasiou
MDA Hellas
Greece
Evy Reviers
ALS Liga Belgium
Belgium
Jean-Philippe Plançon
European Patient Organisation for Dysimmune and Inflammatory Neuropathies (EPODIN)
France
Judit Varadine Csapo
Angyalszarnyak – Hungarian Muscle Dystrophy Association
Hungary
Marisol Montolio
Duchenne Parent Project Spain
Spain
Massimo Marra
CIDP Italia ONLUS
Italy
Patrizia Garzena
CIDP Italia ONLUS
Italy

Members of Patient Advisory Board - Other patient representative
Madelon Kroneman
Spierziekten Nederland
Netherlands
Michela Onali
Gli Equilibristi
Italy